Activation of NK cell granulysin by mycobacteria and IL-15 is differentially affected by HIV

Tuberculosis

Volumn 91, Issue SUPPL. 1, 2011, Pages

  Hogg, Alison ^a   Huante, Matthew ^b   Ongaya, Asiko ^c,d   Williams, Jessica ^b   Ferguson, Monique ^b   Cloyd, Miles ^b   Amukoye, Evans ^c   Endsley, Janice ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d Mt Kenya University   (Kenya)

Author keywords

Granulysin; HIV; NK cells; Tuberculosis

Indexed keywords

BCG VACCINE; GRANULYSIN; INTERLEUKIN 15; INTERLEUKIN 21; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2D; STAT5 PROTEIN;

ARTICLE; BCG VACCINATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPHENOTYPING; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; TUBERCULOSIS;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84655167628     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.10.015     Document Type: Article

References (53)

1. A.P. Junqueira-Kipnis, A. Kipnis, A. Jamieson, M.G. Juarrero, A. Diefenbach, and D.H. Raulet NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection J Immunol 171 2003 6039 6045 (Pubitemid 37467223)
2. R. Vankayalapati, A. Garg, A. Porgador, D.E. Griffith, P. Klucar, and H. Safi Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium J Immunol 175 2005 4611 4617 (Pubitemid 41362000)
3. R. Vankayalapati, B. Wizel, S.E. Weis, H. Safi, D.L. Lakey, and O. Mandelboim The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium J Immunol 168 2002 3451 3457 (Pubitemid 34250410)
4. S.E. Farouk, L. Mincheva-Nilsson, A.M. Krensky, F. Dieli, and M. Troye-Blomberg Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin Eur J Immunol 34 2004 2248 2256 (Pubitemid 39256106)
5. J.J. Endsley, A.G. Torres, C.M. Gonzales, V.G. Kosykh, V.L. Motin, and J.W. Peterson Comparative antimicrobial activity of granulysin against bacterial biothreat agents Open Microbiol J 3 2009 92 96
6. L.L. Ma, J.C. Spurrell, J.F. Wang, G.G. Neely, S. Epelman, and A.M. Krensky CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15 J Immunol 169 2002 5787 5795 (Pubitemid 35291681)
7. S. Stenger, D.A. Hanson, R. Teitelbaum, P. Dewan, K.R. Niazi, and C.J. Froelich An antimicrobial activity of cytolytic T cells mediated by granulysin Science 282 1998 121 125 (Pubitemid 28471143)
8. A. Deng, S. Chen, Q. Li, S.C. Lyu, C. Clayberger, and A.M. Krensky Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator J Immunol 174 2005 5243 5248 (Pubitemid 40593162)
9. +T cells at the site of infection in human chronic pulmonary tuberculosis Infect Immun 75 2007 5210 5222 (Pubitemid 350033607)
10. D. Di Liberto, S. Buccheri, N. Caccamo, S. Meraviglia, A. Romano, and P. Di Carlo Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy Tuberculosis (Edinb) 87 2007 322 328 (Pubitemid 46936240)
11. F. Dieli, G. Sireci, N. Caccamo, C. Di Sano, L. Titone, and A. Romano Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis J Infect Dis 186 2002 1835 1839 (Pubitemid 35469162)
12. J.J. Endsley, J.L. Furrer, M.A. Endsley, M.A. McIntosh, A.C. Maue, and W.R. Waters Characterization of bovine homologues of granulysin and NK-lysin J Immunol 173 2004 2607 2614 (Pubitemid 39063120)
13. J.L. Gansert, V. Kiessler, M. Engele, F. Wittke, M. Rollinghoff, and A.M. Krensky Human NKT cells express granulysin and exhibit antimycobacterial activity J Immunol 170 2003 3154 3161 (Pubitemid 36302192)
14. Y. Kita, M. Okada, T. Nakajima, N. Kanamaru, S. Hashimoto, and T. Nagasawa Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models Hum Vaccin 7 2011 108 114
15. J.P. Houchins, T. Yabe, C. McSherry, N. Miyokawa, and F.H. Bach Isolation and characterization of NK cell or NK/T cell-specific cDNA clones J Mol Cell Immunol 4 1990 295 304
16. S. Latinovic-Golic, M. Walch, H. Sundstrom, C. Dumrese, P. Groscurth, and U. Ziegler Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes BMC Immunol 8 2007 9
17. F. Stegelmann, M. Bastian, K. Swoboda, R. Bhat, V. Kiessler, and A.M. Krensky Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis J Immunol 175 2005 7474 7483 (Pubitemid 41713445)
18. C.R. Diedrich, and J.L. Flynn HIV-1/Mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 79 2011 1407 1417
19. S.D. Lawn, S.T. Butera, and T.M. Shinnick Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis Microbes Infect 4 2002 635 646 (Pubitemid 34614552)
20. C.T. Berger, and G. Alter Natural killer cells in spontaneous control of HIV infection Curr Opin HIV AIDS 6 2011 208 213
21. D. Mavilio, J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, and M.A. Planta Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates Proc Natl Acad Sci U S A 100 2003 15011 15016 (Pubitemid 37518008)
22. A.J. McMichael, and S.L. Rowland-Jones Cellular immune responses to HIV Nature 410 2001 980 987 (Pubitemid 32335849)
23. M.R. Zocchi, A. Rubartelli, P. Morgavi, and A. Poggi HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels J Immunol 161 1998 2938 2943 (Pubitemid 28425717)
24. C.F. Zheng, L.L. Ma, G.J. Jones, M.J. Gill, A.M. Krensky, and P. Kubes Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients Blood 109 2007 2049 2057 (Pubitemid 46348205)
25. A.E. Hogg, G.C. Bowick, N.K. Herzog, M.W. Cloyd, and J.J. Endsley Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1 J Leukoc Biol 86 2009 1191 1203
26. L. White, S. Krishnan, N. Strbo, H. Liu, M.A. Kolber, and M.G. Lichtenheld Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV) Blood 109 2007 3873 3880 (Pubitemid 46641739)
27. N. Strbo, L. de Armas, H. Liu, M.A. Kolber, M. Lichtenheld, and S. Pahwa IL-21 augments natural killer effector functions in chronically HIV-infected individuals Aids 22 2008 1551 1560
28. A. Ahmad, R. Ahmad, A. Iannello, E. Toma, R. Morisset, and S.T. Sindhu IL-15 and HIV infection: lessons for immunotherapy and vaccination Curr HIV Res 3 2005 261 270 (Pubitemid 41052425)
29. I.D. Davis, B. Brady, R.F. Kefford, M. Millward, J. Cebon, and B.K. Skrumsager Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial Clin Cancer Res 15 2009 2123 2129
30. A. Iannello, C. Tremblay, J.P. Routy, M.R. Boulassel, E. Toma, and A. Ahmad Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts Viral Immunol 21 2008 385 388
31. L. Chiossone, C. Vitale, F. Cottalasso, S. Moretti, B. Azzarone, and L. Moretta Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells Blood 109 2007 3767 3775 (Pubitemid 46641727)
32. A. Moustaki, K.V. Argyropoulos, C.N. Baxevanis, M. Papamichail, and S.A. Perez Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function Cancer Immunol Immunother 2011 Jun 26 epub ahead of print
33. S. Roy, P.F. Barnes, A. Garg, S. Wu, D. Cosman, and R. Vankayalapati NK cells lyse T regulatory cells that expand in response to an intracellular pathogen J Immunol 180 2008 1729 1736
34. J.J. Endsley, M.A. Endsley, and D.M. Estes Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages J Leukoc Biol 79 2006 71 79 (Pubitemid 43054251)
35. M. Colonna, S. Jonjic, and C. Watzl Natural killer cells: fighting viruses and much more Nat Immunol 12 2011 107 110
36. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini Functions of natural killer cells Nat Immunol 9 2008 503 510 (Pubitemid 351560519)
37. M.T. Borchers, N.L. Harris, S.C. Wesselkamper, S. Zhang, Y. Chen, and L. Young The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa Infect Immun 74 2006 2578 2586 (Pubitemid 43672965)
38. E.J. Kerschen, D.A. Cohen, A.M. Kaplan, and S.C. Straley The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells Infect Immun 72 2004 4589 4602 (Pubitemid 38989318)
39. H. Shegarfi, K. Sydnes, M. Lovik, M. Inngjerdingen, B. Rolstad, and C. Naper The role of natural killer cells in resistance to the intracellular bacterium Listeria monocytogenes in rats Scand J Immunol 70 2009 238 244
40. C.L. Small, S. McCormick, N. Gill, K. Kugathasan, M. Santosuosso, and N. Donaldson NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung J Immunol 180 2008 5558 5568
41. R. Vankayalapati, and P.F. Barnes Innate and adaptive immune responses to human Mycobacterium tuberculosis infection Tuberculosis (Edinb) 89 Suppl. 1 2009 S77 S80
42. C. Schlapbach, A. Zawodniak, N. Irla, J. Adam, R.E. Hunger, and D. Yerly NKp46(+) cells express granulysin in multiple cutaneous adverse drug reactions Allergy 2011 Aug 5 epub ahead of print
43. W.H. Chung, S.I. Hung, J.Y. Yang, S.C. Su, S.P. Huang, and C.Y. Wei Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis Nat Med 14 2008 1343 1350
44. A. Garg, P.F. Barnes, A. Porgador, S. Roy, S. Wu, and J.S. Nanda Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor J Immunol 177 2006 6192 6198 (Pubitemid 44628837)
45. T. Yabe, C. McSherry, F.H. Bach, and J.P. Houchins A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein J Exp Med 172 1990 1159 1163 (Pubitemid 20343216)
46. L.L. Ma, C.L. Wang, G.G. Neely, S. Epelman, A.M. Krensky, and C.H. Mody NK cells use perforin rather than granulysin for anticryptococcal activity J Immunol 173 2004 3357 3365 (Pubitemid 39142045)
47. P.V. Rao, S. Ramanavelan, S. Rajasekaran, and A. Raja Natural-killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis-role of exogenous interleukins J Clin Immunol 30 2010 393 401
48. S. Kottilil, K. Shin, J.O. Jackson, K.N. Reitano, M.A. O'Shea, and J. Yang Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions J Immunol 176 2006 1107 1114 (Pubitemid 43099712)
49. A. Poggi, R. Carosio, G.M. Spaggiari, C. Fortis, G. Tambussi, and G. Dell'Antonio NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain J Immunol 168 2002 95 101 (Pubitemid 34014107)
50. A. Poggi, and M.R. Zocchi HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin B Clin Dev Immunol 13 2006 369 372 (Pubitemid 44950053)
51. C. Cerboni, F. Neri, N. Casartelli, A. Zingoni, D. Cosman, and P. Rossi Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity J Gen Virol 88 2007 242 250 (Pubitemid 46085135)
52. J. Richard, S. Sindhu, T.N. Pham, J.P. Belzile, and E.A. Cohen HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing Blood 115 2010 1354 1363
53. P.L. Semple, M. Watkins, V. Davids, A.M. Krensky, W.A. Hanekom, and G. Kaplan Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth Clin Dev Immunol 2011 438 463